Asset Management
Build Your Comparison
Side-by-side financial analysisStock Comparison
SSSS vs GAIN vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Banks - Diversified
SSSS vs GAIN vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Asset Management | Asset Management | Banks - Diversified |
| Market Cap | $348M | $612M | $896.00B |
| Revenue (TTM) | $732.03B | $112M | $280.33B |
| Net Income (TTM) | $50M | $195M | $57.05B |
| Gross Margin | 0.0% | 57.9% | 60.0% |
| Operating Margin | 7.9% | 118.5% | 25.9% |
| Forward P/E | 2.9x | 37.9x | 14.4x |
| Total Debt | $73M | $564M | $942.38B |
| Cash & Equiv. | $20M | $1M | $343.34B |
SSSS vs GAIN vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| SuRo Capital Corp. (SSSS) | 100 | 161.7 | +61.7% |
| Gladstone Investmen… (GAIN) | 100 | 150.1 | +50.1% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SSSS vs GAIN vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SSSS is the clearest fit if your priority is growth exposure.
- Rev growth 6.5%, EPS growth 211.2%
- 6.5% NII/revenue growth vs GAIN's -20.5%
- +90.1% vs GAIN's +14.8%
GAIN carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.47, yield 9.6%
- Lower volatility, beta 0.47, Low D/E 84.5%, current ratio 0.01x
- Beta 0.47, yield 9.6%, current ratio 0.01x
JPM is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 465.8% 10Y total return vs SSSS's 365.2%
- PEG 0.81 vs GAIN's 1.26
- Lower P/E (14.4x vs 37.9x), PEG 0.81 vs 1.26
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.5% NII/revenue growth vs GAIN's -20.5% | |
| Value | Lower P/E (14.4x vs 37.9x), PEG 0.81 vs 1.26 | |
| Quality / Margins | 173.6% margin vs SSSS's 0.0% | |
| Stability / Safety | Beta 0.47 vs SSSS's 1.54 | |
| Dividends | 9.6% yield, vs JPM's 1.9% | |
| Momentum (1Y) | +90.1% vs GAIN's +14.8% | |
| Efficiency (ROA) | 16.3% ROA vs SSSS's 0.0%, ROIC 15.5% vs 0.0% |
SSSS vs GAIN vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
SSSS vs GAIN vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
GAIN leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
SSSS is the larger business by revenue, generating $732.0B annually — 6520.2x GAIN's $112M. GAIN is the more profitable business, keeping 173.6% of every revenue dollar as net income compared to SSSS's 0.0%.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $732.0B | $112M | $280.3B |
| EBITDAEarnings before interest/tax | $57.6B | $133M | $81.4B |
| Net IncomeAfter-tax profit | $50M | $195M | $57.0B |
| Free Cash FlowCash after capex | -$5.76T | $26M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +0.0% | +57.9% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +7.9% | +118.5% | +25.9% |
| Net MarginNet income ÷ Revenue | +0.0% | +173.6% | +20.4% |
| FCF MarginFCF ÷ Revenue | -7.9% | +23.6% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +100.0% | +3.2% | +16.0% |
Valuation Metrics
GAIN leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 3.2x trailing earnings, GAIN trades at a 80% valuation discount to JPM's 16.0x P/E. Adjusting for growth (PEG ratio), GAIN offers better value at 0.11x vs JPM's 0.90x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $348M | $612M | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $401M | $1.2B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 7.70x | 3.22x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 2.88x | 37.86x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.11x | 0.90x |
| EV / EBITDAEnterprise value multiple | 7.47x | 5.21x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 9.97x | 8.56x | 3.20x |
| Price / BookPrice ÷ Book value/share | 0.00x | 0.89x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 10.14x | — | 8.88x |
Profitability & Efficiency
GAIN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GAIN delivers a 34.0% return on equity — every $100 of shareholder capital generates $34 in annual profit, vs $0 for SSSS. SSSS carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), JPM scores 5/9 vs GAIN's 4/9, reflecting solid financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | 0.0% | +34.0% | +15.9% |
| ROA (TTM)Return on assets | 0.0% | +16.3% | +1.3% |
| ROICReturn on invested capital | 0.0% | +15.5% | +4.5% |
| ROCEReturn on capital employed | 0.0% | +25.3% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.00x | 0.84x | 2.60x |
| Net DebtTotal debt minus cash | $53M | $563M | $599.0B |
| Cash & Equiv.Liquid assets | $20M | $1M | $343.3B |
| Total DebtShort + long-term debt | $73M | $564M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.05x | 3.48x | 0.74x |
Total Returns (Dividends Reinvested)
SSSS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $13,902 for SSSS. Over the past 12 months, SSSS leads with a +90.1% total return vs GAIN's +14.8%. The 3-year compound annual growth rate (CAGR) favors SSSS at 62.0% vs GAIN's 14.7% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +41.8% | +13.1% | -0.5% |
| 1-Year ReturnPast 12 months | +90.1% | +14.8% | +21.8% |
| 3-Year ReturnCumulative with dividends | +325.1% | +50.8% | +138.2% |
| 5-Year ReturnCumulative with dividends | +39.0% | +55.1% | +118.2% |
| 10-Year ReturnCumulative with dividends | +365.2% | +285.0% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +62.0% | +14.7% | +33.6% |
Risk & Volatility
Evenly matched — GAIN and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
GAIN is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than SSSS's 1.54 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 95.1% from its 52-week high vs GAIN's 89.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.54x | 0.47x | 0.94x |
| 52-Week HighHighest price in past year | $14.98 | $17.14 | $337.25 |
| 52-Week LowLowest price in past year | $7.11 | $13.11 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +91.5% | +89.7% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 55.9 | 41.5 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 333K | 347K | 7.0M |
Analyst Outlook
Evenly matched — GAIN and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SSSS as "Buy", GAIN as "Hold", JPM as "Buy". Consensus price targets imply 10.6% upside for GAIN (target: $17) vs 5.9% for JPM (target: $340). For income investors, GAIN offers the higher dividend yield at 9.61% vs JPM's 1.86%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $15.00 | $17.00 | $339.75 |
| # AnalystsCovering analysts | 5 | 7 | 61 |
| Dividend YieldAnnual dividend ÷ price | +3.0% | +9.6% | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 15 |
| Dividend / ShareAnnual DPS | $0.42 | $1.48 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +3.9% |
GAIN leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). SSSS leads in 1 (Total Returns). 2 tied.
SSSS vs GAIN vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SSSS or GAIN or JPM a better buy right now?
For growth investors, SuRo Capital Corp.
(SSSS) is the stronger pick with 646. 5% revenue growth year-over-year, versus -20. 5% for Gladstone Investment Corporation (GAIN). Gladstone Investment Corporation (GAIN) offers the better valuation at 3. 2x trailing P/E (37. 9x forward), making it the more compelling value choice. Analysts rate SuRo Capital Corp. (SSSS) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SSSS or GAIN or JPM?
On trailing P/E, Gladstone Investment Corporation (GAIN) is the cheapest at 3.
2x versus JPMorgan Chase & Co. at 16. 0x. On forward P/E, SuRo Capital Corp. is actually cheaper at 2. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Gladstone Investment Corporation's 1. 26x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SSSS or GAIN or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to +39. 0% for SuRo Capital Corp. (SSSS). Over 10 years, the gap is even starker: JPM returned +465. 8% versus GAIN's +285. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SSSS or GAIN or JPM?
By beta (market sensitivity over 5 years), Gladstone Investment Corporation (GAIN) is the lower-risk stock at 0.
47β versus SuRo Capital Corp. 's 1. 54β — meaning SSSS is approximately 227% more volatile than GAIN relative to the S&P 500. On balance sheet safety, SuRo Capital Corp. (SSSS) carries a lower debt/equity ratio of 0% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — SSSS or GAIN or JPM?
By revenue growth (latest reported year), SuRo Capital Corp.
(SSSS) is pulling ahead at 646. 5% versus -20. 5% for Gladstone Investment Corporation (GAIN). On earnings-per-share growth, the picture is similar: SuRo Capital Corp. grew EPS 211. 2% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SSSS or GAIN or JPM?
Gladstone Investment Corporation (GAIN) is the more profitable company, earning 258.
5% net margin versus 20. 4% for JPMorgan Chase & Co. — meaning it keeps 258. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GAIN leads at 315. 8% versus 26. 0% for JPM. At the gross margin level — before operating expenses — SSSS leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SSSS or GAIN or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Gladstone Investment Corporation's 1. 26x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, SuRo Capital Corp. (SSSS) trades at 2. 9x forward P/E versus 37. 9x for Gladstone Investment Corporation — 35. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GAIN: 10. 6% to $17. 00.
08Which pays a better dividend — SSSS or GAIN or JPM?
All stocks in this comparison pay dividends.
Gladstone Investment Corporation (GAIN) offers the highest yield at 9. 6%, versus 1. 9% for JPMorgan Chase & Co. (JPM).
09Is SSSS or GAIN or JPM better for a retirement portfolio?
For long-horizon retirement investors, Gladstone Investment Corporation (GAIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
47), 9. 6% yield, +285. 0% 10Y return). SuRo Capital Corp. (SSSS) carries a higher beta of 1. 54 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GAIN: +285. 0%, SSSS: +365. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SSSS and GAIN and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SSSS is a small-cap high-growth stock; GAIN is a small-cap deep-value stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.